Beckman Daniella
CIK 0001513422
Chief Financial OfficerDirector
Filings
19
Latest Feb 4, 2026
Issuers covered
4
Showing
19 of 19
Page 1
Track record
6 of 6 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 6 | 67% | +4.7% | +12.9% | +40.0% | -34.1% |
| 90 days | 6 | 67% | +5.0% | +38.2% | +62.4% | -81.0% |
| 180 days | 4 | 50% | -38.1% | -33.1% | +30.6% | -116.8% |
| 365 days | 4 | 50% | -103.5% | -91.5% | +74.4% | -305.3% |
Issuers
Companies where Beckman Daniella has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| TNGX | Tango Therapeutics, Inc. | 7 | Feb 4, 2026 |
| BPMC | Blueprint Medicines Corp | 6 | Jul 21, 2025 |
| VOR | Vor Biopharma Inc. | 4 | May 23, 2025 |
| UPB | Upstream Bio, Inc. | 2 | Jun 12, 2025 |
All filings
19 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|